AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28

Authors: Demeester, N Mertens, C Caster, H Goethals, M Vandekerckhove, J Rosseneu, M Labeur, C
Citation: N. Demeester et al., Comparison of the aggregation properties, secondary structure and apoptotic effects of wild-type, Flemish and Dutch N-terminally truncated amyloid beta peptides, EUR J NEURO, 13(11), 2001, pp. 2015-2024

Authors: Drouet, B Fifre, A Pincon-Raymond, M Vandekerckhove, J Rosseneu, M Gueant, JL Chambaz, J Pillot, T
Citation: B. Drouet et al., ApoE protects cortical neurones against neurotoxicity induced by the non-fibrillar C-terminal domain of the amyloid-beta peptide, J NEUROCHEM, 76(1), 2001, pp. 117-127

Authors: Peelman, F Vanloo, B Verschelde, JL Labeur, C Caster, H Taveirne, J Verhee, A Duverger, N Vandekerckhove, J Tavernier, J Rosseneu, M
Citation: F. Peelman et al., Effect of mutations of N- and C-terminal charged residues on the activity of LCAT, J LIPID RES, 42(4), 2001, pp. 471-479

Authors: Roosbeek, S Vanloo, B Duverger, N Caster, H Breyne, J De Beun, I Patel, H Vandekerckhove, J Shoulders, C Rosseneu, M Peelman, F
Citation: S. Roosbeek et al., Three arginine residues in apolipoprotein A-I are critical for activation of lecithin : cholesterol acyltransferase, J LIPID RES, 42(1), 2001, pp. 31-40

Authors: Desrumaux, C Labeur, C Verhee, A Tavernier, J Vandekerckhove, J Rosseneu, M Peelman, F
Citation: C. Desrumaux et al., A hydrophobic cluster at the surface of the human plasma phospholipid transfer protein is critical for activity on high density lipoproteins, J BIOL CHEM, 276(8), 2001, pp. 5908-5915

Authors: Chambenoit, O Hamon, Y Marguet, D Rigneault, H Rosseneu, M Chimini, G
Citation: O. Chambenoit et al., Specific docking of apolipoprotein A-I at the cell surface requires a functional ABCA1 transporter, J BIOL CHEM, 276(13), 2001, pp. 9955-9960

Authors: Christiaens, B Vanloo, B Gouyette, C Van Vynckt, I Caster, H Taveirne, J Verhee, A Labeur, C Peelman, F Vandekerckhove, J Tavernier, J Rosseneu, M
Citation: B. Christiaens et al., Headgroup specificity of lecithin cholesterol acyltransferase for monomeric and vesicular phospholipids, BBA-MOL C B, 1486(2-3), 2000, pp. 321-327

Authors: Demeester, N Baier, G Enzinger, C Goethals, M Vandekerckhove, J Rosseneu, M Labeur, C
Citation: N. Demeester et al., Apoptosis induced in neuronal cells by C-terminal amyloid beta-fragments is correlated with their aggregation properties in phospholipid membranes, MOL MEMBR B, 17(4), 2000, pp. 219-228

Authors: Peelman, F Vandekerckhove, J Rosseneu, M
Citation: F. Peelman et al., Structure and function of lecithin cholesterol acyl transferase: new insights from structural predictions and animal models, CURR OP LIP, 11(2), 2000, pp. 155-160

Authors: Demeester, N Castro, G Desrumaux, C De Geitere, C Fruchart, JC Santens, P Mulleners, E Engelborghs, S De Deyn, PP Vandekerckhove, J Rosseneu, M Labeur, C
Citation: N. Demeester et al., Characterization and functional studies of lipoproteins, lipid transfer proteins, and lecithin : cholesterol acyltransferase in CSF of normal individuals and patients with Alzheimer's disease, J LIPID RES, 41(6), 2000, pp. 963-974

Authors: Vanloo, B Peelman, F Deschuymere, K Taveirne, J Verhee, A Gouyette, C Labeur, C Vandekerckhove, J Tavernier, J Rosseneu, M
Citation: B. Vanloo et al., Relationship between structure and biochemical phenotype of lecithin : cholesterol acyltransferase (LCAT) mutants causing fish-eye disease, J LIPID RES, 41(5), 2000, pp. 752-761

Authors: Liu, HQ Labeur, C Xu, CF Ferrell, R Lins, L Brasseur, R Rosseneu, M Weiss, KM Humphries, SE Talmud, PJ
Citation: Hq. Liu et al., Characterization of the lipid-binding properties and lipoprotein lipase inhibition of a novel apolipoprotein C-III variant Ala23Thr, J LIPID RES, 41(11), 2000, pp. 1760-1771

Authors: Read, J Anderson, TA Ritchie, PJ Vanloo, B Amey, J Levitt, D Rosseneu, M Scott, J Shoulders, CC
Citation: J. Read et al., A mechanism of membrane neutral lipid acquisition by the microsomal triglyceride transfer protein, J BIOL CHEM, 275(39), 2000, pp. 30372-30377

Authors: Liu, HQ Talmud, PJ Lins, L Brasseur, R Olivecrona, G Peelman, F Vandekerckhove, J Rosseneu, M Labeur, C
Citation: Hq. Liu et al., Characterization of recombinant wild type and site-directed mutations of apolipoprotein C-III: Lipid binding, displacement of ApoE, and inhibition oflipoprotein lipase, BIOCHEM, 39(31), 2000, pp. 9201-9212

Authors: Decout, A Labeur, C Vanloo, B Goethals, M Vandekerckhove, J Brasseur, R Rosseneu, M
Citation: A. Decout et al., Contribution of the hydrophobicity gradient to the secondary structure andactivity of fusogenic peptides, MOL MEMBR B, 16(3), 1999, pp. 237-246

Authors: Peelman, F Vanloo, B Perez-Mendez, O Decout, A Verschelde, JL Labeur, C Vinaimont, N Verhee, A Duverger, N Brasseur, R Vandekerckhove, J Tavernier, J Rosseneu, M
Citation: F. Peelman et al., Characterization of functional residues in the interfacial recognition domain of lecithin cholesterol acyltransferase (LCAT), PROTEIN ENG, 12(1), 1999, pp. 71-78

Authors: Ritchie, PJ Decout, A Amey, J Mann, CJ Read, J Rosseneu, M Scott, J Shoulders, CC
Citation: Pj. Ritchie et al., Baculovirus expression and biochemical characterization of the human microsomal triglyceride transfer protein, BIOCHEM J, 338, 1999, pp. 305-310

Authors: Pillot, T Drouet, B Queille, S Labeur, C Vandekerckhove, J Rosseneu, M Pincon-Raymond, M Chambaz, J
Citation: T. Pillot et al., The nonfibrillar amyloid beta-peptide induces apoptotic neuronal cell death: Involvement of its C-terminal fusogenic domain, J NEUROCHEM, 73(4), 1999, pp. 1626-1634

Authors: Lins, L Thomas-Soumarmon, A Pillot, T Vandekerckhove, J Rosseneu, M Brasseur, R
Citation: L. Lins et al., Molecular determinants of the interaction between the C-terminal domain ofAlzheimer's beta-amyloid peptide and apolipoprotein E alpha-helices, J NEUROCHEM, 73(2), 1999, pp. 758-769

Authors: Pillot, T Goethals, M Najib, J Labeur, C Lins, L Chambaz, J Brasseur, R Vandekerckhove, J Rosseneu, M
Citation: T. Pillot et al., beta-amyloid peptide interacts specifically with the carboxy-terminal domain of human apolipoprotein E: Relevance to Alzheimer's disease, J NEUROCHEM, 72(1), 1999, pp. 230-237

Authors: Mann, CJ Anderson, TA Read, J Chester, SA Harrison, GB Kochl, S Ritchie, PJ Bradbury, P Hussain, FS Amey, J Vanloo, B Rosseneu, M Infante, R Hancock, JM Levitt, DG Banaszak, LJ Scott, J Shoulders, CC
Citation: Cj. Mann et al., The structure of vitellogenin provides a molecular model for the assembly and secretion of atherogenic lipoproteins, J MOL BIOL, 285(1), 1999, pp. 391-408

Authors: Peelman, F Verschelde, JL Vanloo, B Ampe, C Labeur, C Tavernier, J Vandekerckhove, J Rosseneu, M
Citation: F. Peelman et al., Effects of natural mutations in lecithin : cholesterol acyltransferase on the enzyme structure and activity, J LIPID RES, 40(1), 1999, pp. 59-69

Authors: Rosseneu, M Peelman, F Verschelde, JL Vanloo, B Labeur, C Tavernier, J Vandekerckhove, J
Citation: M. Rosseneu et al., LCAT defects and low HDL levels, ATHEROSCLER, 146, 1999, pp. S9-S9

Authors: Dallongeville, J Tiret, L Visvikis, S O'Reilly, DSJ Saava, M Tsitouris, G Rosseneu, M DeBacker, G Humphries, SE Beisiegel, U
Citation: J. Dallongeville et al., Effect of apo E phenotype on plasma postprandial triglyceride levels in young male adults with and without a familial history of myocardial infarction: the EARS II study, ATHEROSCLER, 145(2), 1999, pp. 381-388

Authors: Brites, FD Cavallero, E de Geitere, C Nicolaiew, N Jacotot, B Rosseneu, M Fruchart, JC Wikinski, RL Castro, GR
Citation: Fd. Brites et al., Abnormal capacity to induce cholesterol efflux and a new LpA-I pre-beta particle in type 2 diabetic patients, CLIN CHIM A, 279(1-2), 1999, pp. 1-14
Risultati: 1-25 | 26-28